Craig Adam R

Avg. Two Year Performance

No purchase track record
89% Avg. Sale Return
37% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return0%0%0%0%0%
Purchase Success Rate0 of 10 of 10 of 10 of 10 of 1
Average Sale Return4%72%71%87%89%
Sale Success Rate1 of 11 of 11 of 11 of 11 of 1
Drugs » Drug Manufacturers - Other

President and CEO, Director:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Biotechnology

EVP, Development & CMO:

Holdings: 23.45K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Other » Other

VP and Chief Medical Officer:

Holdings: shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--